THCCC is a dual metabotropic glutamate receptor 2/3 negative/positive allosteric modulator and a PHCCC analogue. References: Rabin KR, Poplack DG. Management strategies in acute lymphoblastic leukemia. Oncology (Williston Park). 2011 Apr 15;25(4):328-35. Review. Erratum in: Oncology (Williston Park). 2011 May;25(6):551. PubMed PMID: 21618954.

纯度：≥98%

CAS：1259532-01-8